These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 20225655)

  • 1. Prediction models for feverishness developed during interferon therapy of chronic hepatitis C patients.
    Uesawa Y; Motege E; Dai Y; Ishii K; Mohri K
    Pharmazie; 2010 Feb; 65(2):114-6. PubMed ID: 20225655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM
    Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.
    Kumar KS; Russo MW; Borczuk AC; Brown M; Esposito SP; Lobritto SJ; Jacobson IM; Brown RS
    Am J Gastroenterol; 2002 Sep; 97(9):2432-40. PubMed ID: 12358269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between patient profile and feverishness developed during interferon-ribavirin combination therapy of chronic hepatitis C patients].
    Motegi E; Uesawa Y; Dai Y; Ishii K; Mohri K
    Yakugaku Zasshi; 2008 Dec; 128(12):1803-10. PubMed ID: 19043300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selection of therapy in patients with chronic hepatitis C showing features like autoimmune hepatitis].
    Kakumu S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):663-6. PubMed ID: 15359881
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon-induced central retinal vein thrombosis.
    Nazir L; Husain A; Haroon W; Shaikh MI; Mirza SA; Khan Z
    J Coll Physicians Surg Pak; 2012 Nov; 22(11):735-6. PubMed ID: 23146860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe thrombocytopenia with probable autoimmune mechanism associated with interferon therapy in a patient with chronic hepatitis C].
    Carnero-Fernández M; Pineda JR; Lite-Alvarez JM
    Gastroenterol Hepatol; 2006 May; 29(5):297-8. PubMed ID: 16733036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden-onset sarcoidosis with severe dyspnea developing during pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
    Kim SK; Kim SR; Imoto S; Kim CW; Hayashi Y
    Turk J Gastroenterol; 2017 Jan; 28(1):75-76. PubMed ID: 28007686
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complications in interferon therapy for chronic hepatitis C].
    Arase Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):519-22. PubMed ID: 15359854
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon-induced depression: prevalence and management.
    Scalori A; Pozzi M; Bellia V; Apale P; Santamaria G; Bordoni T; Redaelli A; Avolio A; Parravicini P; Pioltelli P; Roffi L
    Dig Liver Dis; 2005 Feb; 37(2):102-7. PubMed ID: 15733522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Splenectomy before antiviral therapy for patients with chronic hepatitis C with thrombocytopenia].
    Aizawa N; Nishiguchi S
    Nihon Rinsho; 2011 May; 69 Suppl 4():201-5. PubMed ID: 22096919
    [No Abstract]   [Full Text] [Related]  

  • 13. Bipolar disorder and interferon treatment: how to manage?
    Aalouane R; Hafidi H; Rammouz I
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):1002. PubMed ID: 23817449
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon caused dysfunction of thyroid in chronic hepatitis C patient: a case report].
    Rao HY; Ma H; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):631. PubMed ID: 20825725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical immunological effect of interferon in cases of influenza].
    Volkova LV; Vorob'eva NN; Bondarenko AL; Sedel'nikova NA; Okishev MA
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):50-3. PubMed ID: 18283734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes and interferon therapy: a nationwide survey in Japan.
    Nakamura K; Kawasaki E; Imagawa A; Awata T; Ikegami H; Uchigata Y; Kobayashi T; Shimada A; Nakanishi K; Makino H; Maruyama T; Hanafusa T;
    Diabetes Care; 2011 Sep; 34(9):2084-9. PubMed ID: 21775762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon therapy: a double-edged sword?
    Cattran DC
    Am J Kidney Dis; 1999 Jun; 33(6):1174-6. PubMed ID: 10352211
    [No Abstract]   [Full Text] [Related]  

  • 18. [Uncommon adverse effects after interferon therapy in patients with hepatitis C].
    Pisabarros Blanco C; Álvarez Cuenllas B; Gutiérrez Torices C; Linares Torres P; Vivas Alegre S
    Gastroenterol Hepatol; 2013 Dec; 36(10):624-5. PubMed ID: 24018313
    [No Abstract]   [Full Text] [Related]  

  • 19. Leptin response in patients undergoing interferon therapy.
    Enjoji M; Nakamuta M; Iwao M; Sugimoto R; Kotoh K; Nawata H; Sakai H
    J Clin Gastroenterol; 2002 Mar; 34(3):287-8. PubMed ID: 11873119
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolated chronic cough during interferon therapy].
    Pileire G; Leclerc P; Hermant P; Meeus E; Camus P
    Presse Med; 1999 May 1-8; 28(17):913. PubMed ID: 10360188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.